STRUCTURAL REQUIREMENTS FOR VIROID PROCESSING BY RNASE T1

被引:27
|
作者
STEGER, G
BAUMSTARK, T
MORCHEN, M
TABLER, M
TSAGRIS, M
SANGER, HL
RIESNER, D
机构
[1] MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY
[2] FDN RES & TECHNOL HELLAS,INST MOLEC BIOL & BIOTECHNOL,GR-71110 IRAKLION,GREECE
关键词
VIROID; RNA SECONDARY STRUCTURE; RNA PROCESSING; RNASE T1; TEMPERATURE-GRADIENT GEL ELECTROPHORESIS;
D O I
10.1016/0022-2836(92)90220-E
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Viroids are replicated via a rolling circle-like mechanism in which (+) strand oligomeric intermediates have to be cleaved enzymatically to unit-length molecules followed by ligation to mature circles. A transcript of potato spindle tuber viroid, which is still infectious, consists of a monomeric molecule with only 22 additional nucleotides, thus doubling part of the central conserved region of viroids. It was shown that this transcript can be cleaved and ligated in vitro to circles by RNase T1. To elucidate the site and mechanism of processing, 16 different site-specific mutants of this longer-than-unit-length transcript were constructed and analyzed by in vitro processing with RNase T1, infectivity studies, temperature-gradient gel electrophoresis, and structure calculations. The wild-type sequence and several mutated transcripts are able to adopt a particular secondary structure which is the prerequisite for enzymatic cleavage and ligation by RNase T1. This "processing structure" exposes both potential cleavage sites in the nearest spatial neighborhood, thus favoring the subsequent ligation to circles. Those mutated sequences for which the formation of the processing structure is impossible or thermodynamically highly unfavored are not processed. The results demonstrate that the particular structural features of viroids enable them to be cleaved and ligated by one and the same enzyme, RNase T1. The in vitro mechanism may serve as a mechanistic model for cellular processing of viroids. © 1992.
引用
收藏
页码:719 / 737
页数:19
相关论文
共 50 条
  • [1] Deciphering the mechanism of RNase T1
    Loverix, S
    Steyaert, J
    [J]. RIBONUCLEASES, PT A, 2001, 341 : 305 - 323
  • [2] Structural analysis of an RNase T1 variant with an altered guanine binding segment
    Höschler, K
    Hoier, H
    Hubner, B
    Saenger, W
    Orth, P
    Hahn, U
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) : 1231 - 1238
  • [3] Dissection of the structural and functional role of a conserved hydration site in RNase T1
    Langhorst, U
    Loris, R
    Denisov, VP
    Doumen, J
    Roose, P
    Maes, D
    Halle, B
    Steyaert, J
    [J]. PROTEIN SCIENCE, 1999, 8 (04) : 722 - 730
  • [4] RNase T1 mimicking artificial ribonuclease
    Mironova, N. L.
    Pyshnyi, D. V.
    Shtadler, D. V.
    Fedorova, A. A.
    Vlassov, V. V.
    Zenkova, M. A.
    [J]. NUCLEIC ACIDS RESEARCH, 2007, 35 (07) : 2356 - 2367
  • [5] SYNTHESIS OF 3'-5' DINCULEOTIDES WITH RNASE T1
    ROWE, MJ
    SMITH, MA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1970, 38 (03) : 393 - &
  • [6] STUDIES ON RNASE T1 MUTANTS AFFECTING ENZYME CATALYSIS
    GRUNERT, HP
    ZOUNI, A
    BEINEKE, M
    QUAAS, R
    GEORGALIS, Y
    SAENGER, W
    HAHN, U
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 197 (01): : 203 - 207
  • [7] SOLUTION STRUCTURE OF RNASE T1 AND ITS COMPLEXES WITH NUCLEOTIDES
    HOFFMANN, E
    SCHMIDT, J
    SIMON, J
    RUTERJANS, H
    [J]. NUCLEOSIDES & NUCLEOTIDES, 1988, 7 (5-6): : 757 - 761
  • [8] SYNTHESIS OF XANTHOSINE-CONTAINING DINUCLEOSIDES BY RNASE T1
    FIKUS, M
    [J]. ACTA BIOCHIMICA POLONICA, 1973, 20 (03) : 237 - 248
  • [9] TESTING THE T1 METHOD - A COMPARISON OF T1(MIN) AND STRUCTURAL DATA
    LUO, XL
    CRABTREE, RH
    [J]. INORGANIC CHEMISTRY, 1990, 29 (15) : 2788 - 2791
  • [10] New Catalytic Residues and Catalytic Mechanism of the RNase T1 Family
    Takebe, Katsuki
    Suzuki, Mamoru
    Hara, Yumiko
    Katsutani, Takuya
    Motoyoshi, Naomi
    Itagaki, Tadashi
    Miyakawa, Shuhei
    Okamoto, Kuniaki
    Fukuzawa, Kaori
    Kobayashi, Hiroko
    [J]. ACS BIO & MED CHEM AU, 2024, 4 (05): : 257 - 267